Efficacy and Safety of the Glucagon Receptor Antagonist PF ‐06291874: A 12‐Week, Randomized, Dose‐Response Study in Patients With Type 2 Diabetes Mellitus on Background Metformin Therapy

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: David J. Kazierad PharmD , Kristin Chidsey MA, MBA , Veena R. Somayaji PhD , Arthur J. Bergman PhD , Roberto A. Calle MD Source Type: research